Cyclerion Therapeutics, Inc. (CYCN)
NASDAQ: CYCN · Real-Time Price · USD
1.505
-0.045 (-2.90%)
At close: Mar 27, 2026, 4:00 PM EDT
1.470
-0.035 (-2.33%)
After-hours: Mar 27, 2026, 7:58 PM EDT
Cyclerion Therapeutics Market Cap
Cyclerion Therapeutics has a market cap or net worth of $5.73 million as of March 27, 2026. Its market cap has decreased by -8.91% in one year.
Market Cap
5.73M
Enterprise Value
1.16M
1-Year Change
-8.91%
Ranking
Category
Stock Price
$1.51
Market Cap Chart
Since March 18, 2019, Cyclerion Therapeutics's market cap has decreased from $193.31M to $5.73M, a decrease of -97.04%. That is a compound annual growth rate of -39.38%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 27, 2026 | 5.73M | 18.50% |
| Dec 31, 2025 | 4.83M | -40.68% |
| Dec 31, 2024 | 8.15M | -0.51% |
| Dec 29, 2023 | 8.19M | -71.30% |
| Dec 30, 2022 | 28.54M | -61.69% |
| Dec 31, 2021 | 74.50M | -28.31% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Mar 18, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Alaunos Therapeutics | 6.65M |
| Immuron | 6.57M |
| Processa Pharmaceuticals | 6.46M |
| SciSparc | 6.34M |
| Xenetic Biosciences | 6.23M |
| MetaVia | 6.21M |
| Ernexa Therapeutics | 5.89M |
| Psyence Biomedical | 5.87M |